Jane Street’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Sell
198,500
-6,200
-3% -$47.4K ﹤0.01% 5617
2025
Q4
$1.99M Sell
204,700
-136,000
-40% -$1.16M ﹤0.01% 4820
2025
Q3
$1.43M Buy
340,700
+3,900
+1% +$24.9K ﹤0.01% 5568
2025
Q2
$3.13M Buy
+336,800
New +$2.94M ﹤0.01% 3689
2024
Q1
Sell
-43,900
Closed -$370K 9935
2023
Q4
$370K Sell
43,900
-9,900
-18% -$115K ﹤0.01% 7293
2023
Q3
$921K Buy
+53,800
New +$1.06M ﹤0.01% 5298
2023
Q1
Sell
-27,500
Closed -$748K 9767
2022
Q4
$748K Hold
27,500
﹤0.01% 5469
2022
Q3
$475K Buy
27,500
+4,500
+20% +$85.8K ﹤0.01% 6780
2022
Q2
$402K Buy
+23,000
New +$378K ﹤0.01% 7125

Other funds holding REPL

Jane Street's REPL Position: Q1 2026 in Review

Jane Street reduced its Replimune Group (REPL) stake by 27% in Q1 2026, selling an estimated $1.19M and leaving 428,145 shares worth $3.28M. The position accounts for ﹤0.01% of the portfolio, ranked #4184.

Jane Street first reported a position in REPL in Q4 2022 and has held it in 13 quarters since. The position peaked at $5.68M in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Jane Street held 428,145 shares of Replimune Group worth $3.28M as of Q1 2026.
  • Jane Street sold 156,185 Replimune Group shares in Q1 2026, an estimated $1.19M.
  • Replimune Group made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4184 holding.
  • Jane Street first reported a position in Replimune Group in Q4 2022 and has held it in 13 quarters since.
  • Jane Street's Replimune Group position peaked at $5.68M in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.